Pharmena S.A. (WSE: PHR)
Poland
· Delayed Price · Currency is PLN 4.840
-0.010 (-0.21%)
Nov 21, 2024, 1:22 PM CET
Pharmena Income Statement
Financials in millions PLN. Fiscal year is January - December.
Millions PLN. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 0.29 | 0.3 | 0.3 | 15.21 | 9.93 | 11.1 | Upgrade
|
| Revenue Growth (YoY) | -4.28% | 0% | -98.03% | 53.16% | -10.51% | -14.88% | Upgrade
|
| Cost of Revenue | 0.04 | 0.13 | 0.15 | 6.79 | 3.55 | 3.7 | Upgrade
|
| Gross Profit | 0.25 | 0.17 | 0.15 | 8.43 | 6.38 | 7.4 | Upgrade
|
| Selling, General & Admin | 3.89 | 4.14 | 3.9 | 12.02 | 12.45 | 17.54 | Upgrade
|
| Other Operating Expenses | -36.92 | -36.77 | 0.31 | 0.47 | 0.07 | 0.11 | Upgrade
|
| Operating Expenses | -33.02 | -32.64 | 4.21 | 12.48 | 12.52 | 17.64 | Upgrade
|
| Operating Income | 33.28 | 32.81 | -4.06 | -4.05 | -6.14 | -10.24 | Upgrade
|
| Interest Expense | - | -0.37 | -0.66 | -0.27 | -0.2 | -0.32 | Upgrade
|
| Interest & Investment Income | 1.08 | 0.43 | - | - | - | 0.03 | Upgrade
|
| Currency Exchange Gain (Loss) | 0.07 | 0.07 | -0.01 | -0.04 | -0.02 | -0.05 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.14 | -0.14 | -0.24 | -0.17 | -0.04 | -0.06 | Upgrade
|
| EBT Excluding Unusual Items | 34.28 | 32.8 | -4.97 | -4.53 | -6.4 | -10.65 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.29 | 0.03 | - | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.02 | 0.02 | 0.01 | 0.04 | - | -0.03 | Upgrade
|
| Other Unusual Items | 0.08 | 0.08 | - | 0.03 | 0.12 | - | Upgrade
|
| Pretax Income | 34.09 | 32.93 | -4.95 | -4.46 | -6.27 | -10.68 | Upgrade
|
| Income Tax Expense | 5.11 | 5.91 | 0.2 | 0.18 | 0.69 | -1.11 | Upgrade
|
| Earnings From Continuing Operations | 28.98 | 27.02 | -5.16 | -4.64 | -6.96 | -9.57 | Upgrade
|
| Earnings From Discontinued Operations | 0.02 | 1.93 | 3.54 | - | - | - | Upgrade
|
| Net Income to Company | 28.99 | 28.95 | -1.62 | -4.64 | -6.96 | -9.57 | Upgrade
|
| Minority Interest in Earnings | 0 | -0.01 | 0.05 | 0.05 | 0.07 | 0.14 | Upgrade
|
| Net Income | 29 | 28.94 | -1.57 | -4.59 | -6.89 | -9.43 | Upgrade
|
| Net Income to Common | 29 | 28.94 | -1.57 | -4.59 | -6.89 | -9.43 | Upgrade
|
| Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 | 10 | Upgrade
|
| Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 11 | 10 | Upgrade
|
| Shares Change (YoY) | - | - | - | 1.25% | 9.87% | 13.85% | Upgrade
|
| EPS (Basic) | 2.60 | 2.60 | -0.14 | -0.41 | -0.63 | -0.94 | Upgrade
|
| EPS (Diluted) | 2.60 | 2.60 | -0.14 | -0.41 | -0.63 | -0.94 | Upgrade
|
| Free Cash Flow | -15.09 | 32.72 | 1.59 | -3.54 | -2.45 | -13.42 | Upgrade
|
| Free Cash Flow Per Share | -1.36 | 2.94 | 0.14 | -0.32 | -0.22 | -1.34 | Upgrade
|
| Dividend Per Share | 0.850 | 0.850 | - | - | - | - | Upgrade
|
| Gross Margin | 87.29% | 58.19% | 50.17% | 55.39% | 64.23% | 66.67% | Upgrade
|
| Operating Margin | 11435.40% | 10972.91% | -1358.19% | -26.65% | -61.76% | -92.30% | Upgrade
|
| Profit Margin | 9964.60% | 9679.26% | -525.08% | -30.18% | -69.37% | -84.96% | Upgrade
|
| Free Cash Flow Margin | -5186.60% | 10942.47% | 532.78% | -23.30% | -24.68% | -120.90% | Upgrade
|
| EBITDA | 33.14 | 32.88 | -3.95 | -3.86 | -5.81 | -9.98 | Upgrade
|
| EBITDA Margin | 11387.97% | 10997.66% | - | -25.35% | -58.53% | -89.94% | Upgrade
|
| D&A For EBITDA | -0.14 | 0.07 | 0.11 | 0.2 | 0.32 | 0.26 | Upgrade
|
| EBIT | 33.28 | 32.81 | -4.06 | -4.05 | -6.14 | -10.24 | Upgrade
|
| EBIT Margin | 11435.40% | 10972.91% | - | -26.65% | -61.76% | -92.30% | Upgrade
|
| Effective Tax Rate | 15.00% | 17.94% | - | - | - | - | Upgrade
|
| Advertising Expenses | - | 0.18 | 0.06 | 0.6 | 1.09 | 4.53 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.